Background illustration for clinical trials search

Paid Clinical Trials Boston

Discover 3,070 paid clinical trials in Boston, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

for
Craniopharyngioma, Child, Craniopharyngioma,
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Sabine Mueller, MD, PhD

Sex: All

Age: 1 - 39

Code: NCT05465174

Phase2, Recruiting

Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation

for
Chronic Lymphocytic Leukemia, Richter's Transformation
Location: Boston MA, Chapel Hill NC, Columbus OH, Atlanta GA
Sponsor: Christine Ryan

Sex: All

Age: 18+

Code: NCT06043674

Phase2, Recruiting

Understanding Chronic Lymphocytic Leukemia

for
Chronic Lymphocytic Leukemia
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04028531

Recruiting

Tracking Response to Antidepressants in Advance of Investigational Trials

for
Major Depressive Disorder
Location: Watertown MA
Sponsor: Adams Clinical

Sex: All

Age: 18+

Code: NCT04748276

Recruiting

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

for
Neoplasms, Neoplasm Metastasis, Non-Small-Cell Lung Cancer
Location: Boston MA, Canton OH, Detroit MI
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT03797391

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

for
Castrate Resistant Prostate Cancer, NUT Carcinoma,
Location: Boston MA, Jacksonville FL, Rochester MN, Houston TX,
Sponsor: Epigenetix, Inc.

Sex: All

Age: 18+

Code: NCT05488548

Phase1, Recruiting

The COMPASSION Study

for
Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06507930

Recruiting

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

for
Advanced Lung Neuroendocrine Tumor,
Location: Boston MA, Philadelphia PA, Pittsburgh PA, Cleveland OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04665739

Phase2, Recruiting

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

for
Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Location: Boston MA, Hackensack NJ, New York NY, Rochester NY,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 8+

Code: NCT06098430

Recruiting

Pembro Plus CAR T-cell Therapy in R/R in PMBCL

for
Primary Mediastinal Large B-cell Lymphoma (PMBCL),
Location: Boston MA, New York NY
Sponsor: Jennifer Crombie, MD

Sex: All

Age: 18+

Code: NCT05934448

Phase2, Recruiting

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Location: Boston MA, Montreal, Philadelphia PA,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 0 - 21

Code: NCT04655404

Early_phase1, Recruiting

IS-free Treg HaploHCT

for
Stem Cell Transplant Complications, Graft Vs Host Disease,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18 - 70+

Code: NCT04678401

Phase1, Recruiting

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, Pittsburgh PA, Houston TX, Newport Beach CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT05372640

Phase1, Recruiting

Lurbinectedin in FET-Fused Tumors

for
Ewing Sarcoma, Desmoplastic Small Round Cell Tumor,
Location: Boston MA, New York NY, Philadelphia PA, Ann Arbor MI,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 10+

Code: NCT05918640

Phase1, Phase2, Recruiting

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

for
Solid Tumor, Adult
Location: Boston MA, New Haven CT, Chicago IL, Birmingham AL,
Sponsor: Corbus Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06265727

Phase1, Phase2, Recruiting

Asthma Link Effectiveness Trial

for
Childhood Asthma
Location: Worcester MA
Sponsor: University of Massachusetts, Worcester

Sex: All

Age: 5 - 14

Code: NCT06388460

Recruiting

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, New York NY, Hillsborough NC, Nashville TN,
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT06375044

Phase1, Recruiting

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

for
Biliary Tract Cancer, Breast Cancer, Cervical Cancer,
Location: Boston MA, Denver CO, Nashville TN, Miami FL,
Sponsor: ModeX Therapeutics, An OPKO Health Company

Sex: All

Age: 18+

Code: NCT06239194

Phase1, Phase2, Recruiting

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

for
Advanced Solid Tumor Cancer
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Calico Life Sciences LLC

Sex: All

Age: 18+

Code: NCT04777994

Phase1, Recruiting

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

for
Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme,
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06810544

Phase1, Phase2, Recruiting

With its world-renowned healthcare network and prestigious medical research institutions, Boston is a premier destination for a wide range of clinical trials. Major centers such as Massachusetts General Hospital, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, and the Dana-Farber Cancer Institute lead groundbreaking studies across various medical fields. These institutions are at the forefront of innovation, making Boston a hub for cutting-edge clinical research.

Why choose Boston for clinical trials?

Boston stands out as a leader in healthcare and life science, and has become an important destination for participants taking part in clinical trials. With world-class medical institutions and a diverse patient population, researchers can deliver more reliable and relevant results.

The city is also home to an innovative research ecosystem, strengthened by close collaborations between hospitals, universities, and biotech companies, making it a hub for cutting-edge clinical studies.

Common conditions studied in Boston

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Boston